US Stock MarketDetailed Quotes

AVTX Avalo Therapeutics

Watchlist

8.8100
-0.2800-3.08%

Close Dec 24 13:00 ET

92.18MMarket Cap0.09P/E (TTM)

Avalo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

5.51%249K

-89.34%1.92M

-36.27%571K

-98.42%236K

-37.75%643K

-59.51%475K

234.40%18.05M

309.13%896K

Operating revenue

5.51%249K

--0

-89.34%1.92M

-36.27%571K

-98.42%236K

-37.75%643K

-59.51%475K

234.40%18.05M

309.13%896K

Cost of revenue

-389.07%-714K

-51.55%343K

-114.52%-80K

-62.61%1.28M

-135.65%-221K

-53.22%247K

-54.82%708K

-23.47%551K

130.32%3.43M

46.23%620K

Gross profit

8,854.55%963K

-427.69%-343K

205.26%80K

-95.62%640K

186.96%792K

-100.08%-11K

87.83%-65K

-116.78%-76K

274.12%14.62M

234.63%276K

Operating expense

269.72%13.82M

28.85%9.13M

-39.09%5.31M

-53.74%24.08M

-50.25%4.54M

-63.79%3.74M

-37.27%7.09M

-59.09%8.72M

-39.50%52.06M

-48.58%9.13M

Selling and administrative expenses

72.13%4.29M

86.57%4.53M

17.91%3.19M

-50.27%10.3M

-9.56%2.68M

-24.18%2.49M

-12.82%2.43M

-76.82%2.71M

-16.01%20.71M

-50.53%2.96M

-Selling and marketing expense

----

200.00%21K

-46.15%7K

-56.58%33K

----

-50.00%7K

-69.77%13K

-95.41%76K

-98.04%12K

-General and administrative expense

72.13%4.29M

86.24%4.51M

18.22%3.19M

-50.24%10.27M

-10.32%2.64M

-24.04%2.49M

-12.64%2.42M

-76.85%2.7M

-10.29%20.64M

-45.10%2.95M

Research and development costs

663.65%9.54M

-1.22%4.6M

-64.78%2.12M

-55.97%13.78M

-69.75%1.87M

-82.26%1.25M

-45.26%4.66M

-37.31%6.01M

-47.68%31.31M

-46.38%6.17M

Depreciation amortization depletion

----

--0

----

-97.55%38K

--0

-Depreciation and amortization

----

--0

----

-97.55%38K

--0

Operating profit

-242.96%-12.86M

-32.48%-9.47M

40.53%-5.23M

37.38%-23.44M

57.64%-3.75M

-191.58%-3.75M

39.55%-7.15M

57.84%-8.79M

54.42%-37.44M

50.70%-8.86M

Net non-operating interest income expense

162.07%964K

204.32%1.04M

110.54%100K

18.06%-3.42M

108.54%81K

-72.94%-1.55M

13.69%-996K

18.82%-949K

-74.40%-4.17M

19.85%-949K

Non-operating interest income

----

--100K

----

Non-operating interest expense

----

-18.06%3.42M

----

-18.82%949K

74.40%4.17M

-19.85%949K

Total other finance cost

-162.07%-964K

-204.32%-1.04M

----

--1.55M

--996K

----

Other net income (expense)

41,972.29%34.92M

267,357.50%106.9M

-56,285.44%-116.15M

-23,245.00%-4.67M

-4.51M

83K

-40K

-930.00%-206K

0.00%-20K

Gain on sale of security

34,825.00%34.93M

267,615.00%107.01M

-44,008.89%-79.4M

---720K

---600K

--100K

---40K

---180K

----

Special income (charges)

--0

---103K

---36.76M

---3.91M

--0

----

-Less：Restructuring and merger&acquisition

--0

--9.22M

----

--0

----

-Less:Impairment of capital assets

----

--3.91M

----

--0

----

-Less:Other special charges

----

--103K

--27.54M

----

Other non- operating income (expenses)

70.59%-5K

----

-110.00%-42K

--0

---17K

----

-30.00%-26K

0.00%-20K

--0

Income before tax

541.05%23.02M

1,302.91%98.47M

-1,119.29%-121.28M

24.26%-31.53M

16.60%-8.18M

-263.28%-5.22M

36.94%-8.19M

54.87%-9.95M

50.76%-41.63M

48.80%-9.8M

Income tax

-275.00%-14K

0.00%7K

-12.50%7K

-50.00%14K

-212.50%-9K

60.00%8K

40.00%7K

-11.11%8K

114.29%28K

150.00%8K

Net income

540.65%23.04M

1,301.79%98.46M

-1,118.38%-121.29M

24.28%-31.54M

16.75%-8.17M

-263.78%-5.23M

36.91%-8.19M

54.85%-9.96M

50.63%-41.66M

48.89%-9.81M

Net income continuous Operations

540.65%23.04M

1,301.79%98.46M

-1,118.38%-121.29M

24.28%-31.54M

16.75%-8.17M

-263.78%-5.23M

36.91%-8.19M

54.85%-9.96M

50.61%-41.66M

48.71%-9.81M

Minority interest income

Net income attributable to the parent company

540.65%23.04M

1,301.79%98.46M

-1,118.38%-121.29M

24.28%-31.54M

16.75%-8.17M

-263.78%-5.23M

36.91%-8.19M

54.85%-9.96M

50.63%-41.66M

48.89%-9.81M

Preferred stock dividends

Other preferred stock dividends

17.58M

94.11M

Net income attributable to common stockholders

204.48%5.46M

153.14%4.35M

-1,118.38%-121.29M

24.28%-31.54M

16.75%-8.17M

-263.78%-5.23M

36.91%-8.19M

54.85%-9.96M

50.63%-41.66M

48.89%-9.81M

Basic earnings per share

103.65%0.98

817.97%1.01K

30.88%-141

89.28%-114

95.92%-10.1878

-132.88%-26.83

57.51%-140.73

63.83%-204

55.49%-1.06K

46.16%-249.4

Diluted earnings per share

89.45%-2.83

-2,299.49%-3.38K

30.88%-141

89.28%-114

95.92%-10.1878

-132.88%-26.83

57.51%-140.73

63.83%-204

55.49%-1.06K

46.16%-249.4

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	5.51%249K	0	0	-89.34%1.92M	-36.27%571K	-98.42%236K	-37.75%643K	-59.51%475K	234.40%18.05M	309.13%896K
Operating revenue	5.51%249K	--0	--0	-89.34%1.92M	-36.27%571K	-98.42%236K	-37.75%643K	-59.51%475K	234.40%18.05M	309.13%896K
Cost of revenue	-389.07%-714K	-51.55%343K	-114.52%-80K	-62.61%1.28M	-135.65%-221K	-53.22%247K	-54.82%708K	-23.47%551K	130.32%3.43M	46.23%620K
Gross profit	8,854.55%963K	-427.69%-343K	205.26%80K	-95.62%640K	186.96%792K	-100.08%-11K	87.83%-65K	-116.78%-76K	274.12%14.62M	234.63%276K
Operating expense	269.72%13.82M	28.85%9.13M	-39.09%5.31M	-53.74%24.08M	-50.25%4.54M	-63.79%3.74M	-37.27%7.09M	-59.09%8.72M	-39.50%52.06M	-48.58%9.13M
Selling and administrative expenses	72.13%4.29M	86.57%4.53M	17.91%3.19M	-50.27%10.3M	-9.56%2.68M	-24.18%2.49M	-12.82%2.43M	-76.82%2.71M	-16.01%20.71M	-50.53%2.96M
-Selling and marketing expense	----	200.00%21K	-46.15%7K	-56.58%33K	----	----	-50.00%7K	-69.77%13K	-95.41%76K	-98.04%12K
-General and administrative expense	72.13%4.29M	86.24%4.51M	18.22%3.19M	-50.24%10.27M	-10.32%2.64M	-24.04%2.49M	-12.64%2.42M	-76.85%2.7M	-10.29%20.64M	-45.10%2.95M
Research and development costs	663.65%9.54M	-1.22%4.6M	-64.78%2.12M	-55.97%13.78M	-69.75%1.87M	-82.26%1.25M	-45.26%4.66M	-37.31%6.01M	-47.68%31.31M	-46.38%6.17M
Depreciation amortization depletion	----	----	----	--0	----	----	----	----	-97.55%38K	--0
-Depreciation and amortization	----	----	----	--0	----	----	----	----	-97.55%38K	--0
Operating profit	-242.96%-12.86M	-32.48%-9.47M	40.53%-5.23M	37.38%-23.44M	57.64%-3.75M	-191.58%-3.75M	39.55%-7.15M	57.84%-8.79M	54.42%-37.44M	50.70%-8.86M
Net non-operating interest income expense	162.07%964K	204.32%1.04M	110.54%100K	18.06%-3.42M	108.54%81K	-72.94%-1.55M	13.69%-996K	18.82%-949K	-74.40%-4.17M	19.85%-949K
Non-operating interest income	----	----	--100K	----	----	----	----	----	----	----
Non-operating interest expense	----	----	----	-18.06%3.42M	----	----	----	-18.82%949K	74.40%4.17M	-19.85%949K
Total other finance cost	-162.07%-964K	-204.32%-1.04M	----	----	----	--1.55M	--996K	----	----	----
Other net income (expense)	41,972.29%34.92M	267,357.50%106.9M	-56,285.44%-116.15M	-23,245.00%-4.67M	-4.51M	83K	-40K	-930.00%-206K	0.00%-20K	0
Gain on sale of security	34,825.00%34.93M	267,615.00%107.01M	-44,008.89%-79.4M	---720K	---600K	--100K	---40K	---180K	----	----
Special income (charges)	--0	---103K	---36.76M	---3.91M	---3.91M	--0	--0	--0	--0	----
-Less：Restructuring and merger&acquisition	--0	--0	--9.22M	----	----	--0	--0	--0	----	----
-Less:Impairment of capital assets	----	----	----	--3.91M	----	----	----	----	--0	----
-Less:Other special charges	----	--103K	--27.54M	----	----	----	----	----	----	----
Other non- operating income (expenses)	70.59%-5K	----	----	-110.00%-42K	--0	---17K	----	-30.00%-26K	0.00%-20K	--0
Income before tax	541.05%23.02M	1,302.91%98.47M	-1,119.29%-121.28M	24.26%-31.53M	16.60%-8.18M	-263.28%-5.22M	36.94%-8.19M	54.87%-9.95M	50.76%-41.63M	48.80%-9.8M
Income tax	-275.00%-14K	0.00%7K	-12.50%7K	-50.00%14K	-212.50%-9K	60.00%8K	40.00%7K	-11.11%8K	114.29%28K	150.00%8K
Net income	540.65%23.04M	1,301.79%98.46M	-1,118.38%-121.29M	24.28%-31.54M	16.75%-8.17M	-263.78%-5.23M	36.91%-8.19M	54.85%-9.96M	50.63%-41.66M	48.89%-9.81M
Net income continuous Operations	540.65%23.04M	1,301.79%98.46M	-1,118.38%-121.29M	24.28%-31.54M	16.75%-8.17M	-263.78%-5.23M	36.91%-8.19M	54.85%-9.96M	50.61%-41.66M	48.71%-9.81M
Minority interest income
Net income attributable to the parent company	540.65%23.04M	1,301.79%98.46M	-1,118.38%-121.29M	24.28%-31.54M	16.75%-8.17M	-263.78%-5.23M	36.91%-8.19M	54.85%-9.96M	50.63%-41.66M	48.89%-9.81M
Preferred stock dividends
Other preferred stock dividends	17.58M	94.11M
Net income attributable to common stockholders	204.48%5.46M	153.14%4.35M	-1,118.38%-121.29M	24.28%-31.54M	16.75%-8.17M	-263.78%-5.23M	36.91%-8.19M	54.85%-9.96M	50.63%-41.66M	48.89%-9.81M
Basic earnings per share	103.65%0.98	817.97%1.01K	30.88%-141	89.28%-114	95.92%-10.1878	-132.88%-26.83	57.51%-140.73	63.83%-204	55.49%-1.06K	46.16%-249.4
Diluted earnings per share	89.45%-2.83	-2,299.49%-3.38K	30.88%-141	89.28%-114	95.92%-10.1878	-132.88%-26.83	57.51%-140.73	63.83%-204	55.49%-1.06K	46.16%-249.4
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Heat List

Overall

No Data